Close
ACHEMA MIDDLE EAST 2026

Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India

Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...

Halaven – Treatment of Metastatic Breast Cancer, Japan

Halaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai submitted a new drug...

Pharmaceutical firms seek larger product-liability cover after regulatory action

Pharmaceutical companies in India are seeking larger product-liability insurance cover as they face an increase in compliance costs due to regulatory action by the...

Bayer seeks marketing authorisation of aflibercept solution for injection in Japan

Bayer Yakuhin has tendered a new application in Japan for marketing authorisation for its aflibercept solution for injection in the eye. The company submitted...

Jinan Asia Pharmaceutical Opens US Branch

Jinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is one of the global...

Wockhardt Might Be Next Acquisition Target For US Pharmaceuticals

Wockhardt Limited, an Indian pharmaceutical and biotech firm, might be a good acquisition target amidst the rising trend of mergers and acquisitions (M&A) in...

China’s pharmaceutical company launches operations in U.S.

Tasly Holding Group, a leading pharmaceutical company in China, officially launched its North American operations in the state of Maryland Wednesday as part of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...